MedTrace Logo

Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation

NCT06829446 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2025-02-17

No results posted yet for this study

Summary

This is an open label, randomized parallel control clinical trial, to compare extra-PV extensive ablation with in-situ ablation as two strategies for the treatment of PerAF to identify the mechanisms of PerAF recurrence.

Conditions

  • Recurrent Persistent Atrial Fibrillation

Interventions

PROCEDURE

Extra-PV extensive ablation

Extra-PV extensive ablation

PROCEDURE

Repeat same PVI and linear ablation as the first procedure

Repeat same PVI and linear ablation as the first procedure

Sponsors & Collaborators

  • Jinshan Hospital Affiliated to Fudan University

    collaborator UNKNOWN

  • Tongji University

    collaborator OTHER

  • Shanghai Chest Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06829446 on ClinicalTrials.gov